Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
    Journal Article

    Dixon, B. N.; Daley, R. J.; Buie, L. W.; Hsu, M.; Park, J. H.; Brentjens, R. J.; Purdon, T. J.; Latcha, S.
    Clinical Nephrology (2020)

    Fulltext@MSK | Save
  • Impaired cell fate through gain-of-function mutations in a chromatin reader
    Journal Article

    Wan, L.; Chong, S.; Xuan, F.; Liang, A.; Cui, X.; Gates, L.; Carroll, T. S.; Li, Y.; Feng, L.; Chen, G.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: A retrospective cohort study
    Journal Article

    Petersdorf, E. W.; Carrington, M.; O'hUigin, C.; Bengtsson, M.; De Santis, D.; Dubois, V.; Gooley, T.; Horowitz, M.; Hsu, K.; Madrigal, J. A.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Monoclonal gammopathies
    Book Section

    Murata, K.; McCash, S.; Landgren, C. O.
    In Rich, R. R.; Fleisher, T. A.; Shearer, W. T.; Schroeder, H. W. Jr; Frew, A. J.; Weyand, C. M (Eds.) Clinical Immunology: Principles and Practice. 5th ed (2019)

    Fulltext@MSK | Save
  • Epichaperome abundance predicts response to the epichaperome inhibitor, Puh-71, in acute myeloid leukemia
    Meeting Abstract

    Tavakkoli, M.; Kaner, J. D.; Sahil, S.; Taldone, T.; Merugu, S.; Chiosis, G.; Roboz, G. J.; Guzman, M. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Peripheral neuropathy in MGUS and progression to amyloid light-chain amyloidosis: A population-based study including 15,351 MGUS cases
    Meeting Abstract

    Rognvaldsson, S.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Blood (2019)

    Fulltext@MSK | Save
  • Safety, clinical activity, pharmacokinetics, and pharmacodynamics from a phase I study of PF-06863135, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Raje, N. S.; Jakubowiak, A.; Gasparetto, C.; Cornell, R. F.; Krupka, H. I.; Navarro, D.; Forgie, A. J.; Udata, C.; Basu, C.; Chou, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • VTE rates and safety analysis of newly diagnosed multiple myeloma patients receiving carfilzomib-lenalidomide-dexamethasone (KRD) with or without rivaroxaban prophylaxis
    Meeting Abstract

    Piedra, K. M.; Hassoun, H.; Buie, L. W.; Devlin, S. M.; Flynn, J.; Hultcrantz, M.; Lesokhin, A. M.; Lu, S. X.; Mailankody, S.; Shah, U. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save